期刊文献+

气相色谱法同时测定盐酸伊立替康中8种残留溶剂 被引量:1

Simultaneous Determination of Eight Residual Solvents in Irinotecan Hydrochloride by Gas Chromatography
下载PDF
导出
摘要 目的:建立盐酸伊立替康中8种有机溶剂残留量的分离测定方法。方法:采用气相色谱法,色谱柱为SE-54(50m×0.53mm×1.0μm),氢火焰离子化检测器(FID),氮气为载气,程序升温,N,N-二甲基甲酰胺为溶解介质,二氯乙烷为内标物。结果:8种有机溶剂完全分离,线性关系与精密度良好。结论:本方法可用于盐酸伊立替康中有机溶剂残留量的检测。 Objective: To develop a method for determination of eight residual solvents in irinotecan hydrochloride. Methods: The residual solvents were determined by GC on SE--54 column(50m×0.53mm×1.0μm)with FID detector, nitrogen as the carrier, N, N-dimethylformamide(DMF) as solvent media, 1,2-diehloroethane as internal standard, the column temperature rose by program. Results:The eight residual solvents in irinotecan hydrochloride can be completely separated, and the calibration curves of each solvent were linear, precision was good too. Conclusion:The method is accurate and reliable. It is suitable for detection of residual sol- vents in irinotecan hydrochloride.
出处 《亚太传统医药》 2011年第1期23-25,共3页 Asia-Pacific Traditional Medicine
关键词 盐酸伊立替康 残留溶剂 气相色谱法 Irinotecan Hydrochloride Residual Solvents GC
  • 相关文献

参考文献7

二级参考文献35

  • 1吴锦慧,王秋娟,胡松,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对大鼠的降压作用[J].中国药科大学学报,2005,36(6):563-566. 被引量:7
  • 2韩桂茹,陈太平,杨建红,戴敬,徐韧柳,张永泉,冈野二郎,油井磊辅,中岛广光,浜崎敞.中药中有机氯农药残留量的研究[J].中国中药杂志,1996,21(10):591-594. 被引量:43
  • 3张斐,李小敏,涂秀芹,许向阳,陈峻崧.伏格列波糖中有机溶剂残留量的毛细管GC测定[J].中国医药工业杂志,2006,37(11):773-774. 被引量:2
  • 4王玉,王秋娟,吴锦慧,徐进宜,吴晓明.新型AT_1受体拮抗剂Ⅰb对血管紧张素Ⅱ的拮抗作用[J].中国药科大学学报,2007,38(1):69-72. 被引量:3
  • 5ZHANGXue—hui(张学慧) eta1.ZHANGShu—min(张树民),CHENJian一删n(陈见民),Study on pesticide residues in 23 kinds of Chinese mediciIlal materials(23种中草药农药残留研究)[J].药学学报,2003,37(11):904-904. 被引量:1
  • 6YAN B,WANG GJ,SUN JG,et al. Identification of the major metabolites of 5-n-butyl -4-{ 4-[ 2-( 1 H-tetrazole-5-yl ) -1H-pyrrol-1 - yl ] phenylmethy } -2,4-dihydro-2- ( 2,6-dichloridephenyl ) -3 H-1, 2,4-triazol-3-one, a new angiotensin type 1 receptor antagonist in rat bile by HPLC-diode array detection-MS and HPLC-MS/MS [ J ]. Biomedical Chromatography,2007,21:912 - 924. 被引量:1
  • 7YAN B, WANG GJ, SUN JG, et al. Determination of 5-n-butyl-4-{ 4-[ 2-( 1H-tetrazole -5-yl ) -1H -pyrrol-1 -yl ] phenylmethy } -2,4-dihydro-2- ( 2,6-dichloridephenyl ) -3 H-1, 2,4-triazol-3 -one, a new angiotensin type 1 receptor antagonist in rat plasma by LC-ESIMS : application to pharmacokinetic studies [ J ]. Chromatographia, 2007,66:55 -61. 被引量:1
  • 8Cersosmio RJ. Irinotecan: a new antineoplastic agent for the management of colorectal cancer[J].Ann Pharmacother,1998, 32(12) :1324 - 1333. 被引量:1
  • 9Rivory LP, Chatelut E; Canal P ,et al. Kinetics of the in vivo inter-conversion of the carboxylatee and lactone forms of irinoteacan (CPT-11) and of its metabohte SN-38 in patients[J]. Cancer Res,1994, 54(24):6330-6333. 被引量:1
  • 10Ratain MJ. Insights into the phamacokinetics and pharmacodynamics of irinotecan[J]. Clin Cancer Res. 2000, 6(9) : 3393 - 3394. 被引量:1

共引文献52

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部